While Zimmer Biomet has lagged behind the broader market over the past year, analysts continue to hold a moderately positive view on the stock's prospects.
Zimmer Biomet's ZBH strategic product launches and stabilizing market trends bolster our confidence in this stock. Yet, factors like macroeconomic uncertainties put pressure on the bottom line. The stock...
Zimmer Biomet Holdings is expected to release its third-quarter earnings later this month, and analysts expect a single-digit earnings growth.
Smith & Nephew SNATSÂ SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions,...
Morningstar recently ranked the 10 most undervalued stocks to buy in October. I found three unusually active options that stood out as attractive bets on these struggling stocks.
Solventum outperformed the broader market recently, but Wall Street analysts remain cautious about the stock’s prospects.
STERIS has underperformed the S&P 500 over the past year, yet analysts remain moderately bullish about the stock’s potential.
Zimmer Biomet has underperformed the healthcare sector over the past year, yet analysts remain moderately bullish about the stock’s prospects.
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.05%. Stocks on Thursday...